Full-Time

Senior Social Media Manager

Posted on 12/8/2025

Niagen Bioscience

Niagen Bioscience

51-200 employees

Advances NAD+ science; consumer products

Compensation Overview

$120k - $135k/yr

Westwood, CA, USA

Hybrid

Category
Social Media (1)
Requirements
  • Bachelor’s degree in Marketing, Communications, Digital Media, or a related field; advanced degree strongly preferred
  • 7+ years of professional social media marketing experience, with demonstrated success in competitive, regulated, or scientific industries (bioscience, health, wellness, biotechnology, or technology)
  • Proven ability to lead channel strategy across Instagram, TikTok, LinkedIn, YouTube, Facebook, Reddit and X/Twitter
  • Strong creative vision with the ability to turn scientific concepts into compelling, consumer-friendly storytelling
  • Expertise with social media management platforms (e.g., Meltwater and Later) and digital analytics tools
  • Working knowledge of SEO, content marketing, and paid social fundamentals
Responsibilities
  • Develop and own the end-to-end social media and community strategy, aligning channel direction with brand, product, and business goals across bioscience, health, and wellness audiences
  • Establish the long-term vision for social platforms, identifying where Niagen should innovate, invest, and differentiate
  • Set annual and quarterly KPIs, lead reporting cadences, and communicate insights and recommendations to senior leadership
  • Continuously assess the social and digital competitive landscape to identify trends, opportunities, and risks that inform channel strategy and content direction
  • Oversee the creation of high-quality, scientifically accurate, and visually elevated content including videos, animations, graphics, stories, and multi-channel campaigns
  • Lead ideation and ensure content meets both creative excellence and regulatory standards, including FDA guidelines for claims
  • Drive experimentation with emerging formats, such as short-form video and interactive content
  • Partner closely with Marketing, Creative, Scientific Affairs, Research, Product Development, and Sales to ensure scientific precision and cohesive brand storytelling
  • Provide direction and feedback to internal creators, agencies, freelancers, and production vendors/designers
  • Mentor junior team members, offering guidance on strategy, creative thinking, and platform best practices
  • Oversee analytics across platforms using tools such as Meltwater and Later
  • Analyze engagement, reach, traffic, conversions, and sentiment—translating data into actionable optimization strategies
  • Manage crisis and reputation moments proactively, responding with strategic clarity and cross-functional alignment
Desired Qualifications
  • Advanced degree strongly preferred

Niagen Bioscience focuses on NAD+ science and cellular health, offering Tru Niagen and Niagen Plus consumer products, licensing nicotinamide riboside (NR) to manufacturers, and providing analytical reference standards for research labs. Its flagship ingredient, Niagen, aims to raise cellular NAD+ levels to support mitochondrial function, DNA repair, and metabolism. The company differentiates itself through a 25+-year research history, 35+ human clinical studies, 50+ patents, and partnerships with leading aging biology researchers. Its goal is to extend human healthspan by restoring NAD+ levels and enabling science-based aging interventions across pharma and wellness partnerships.

Company Size

51-200

Company Stage

IPO

Headquarters

Los Angeles, California

Founded

1999

Simplify Jobs

Simplify's Take

What believers are saying

  • Q1 2026 revenue hit $31.5M with 14% e-commerce growth and $66.5M cash.
  • OneSpaWorld partnership adds 80 cruise ship clinics to 1,200+ US sites.
  • Niagen Plus telehealth launches at-home injection kits for $223B injectable market.

What critics are saying

  • NAD challenged Niagen's Tru Niagen claims in March 2026, forcing modifications.
  • FDA Category 2 status limits 503B compounding, cutting clinic partnerships 40%.
  • Elysium Health captures 25% US NAD+ sales by Q1 2026 via lower pricing.

What makes Niagen Bioscience unique

  • Niagen holds 50 patents on nicotinamide riboside, protecting NR through 2044.
  • USP monograph establishes Niagen as sole NAD+ supplement with published standards.
  • Niagen NanoCloud uses waterless sachets to prevent NAD+ degradation in skincare.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Niagen Bioscience who can refer or advise you

Benefits

Health Insurance

Wellness Program

Retirement savings with company match

Paid Time Off

Flexible Work Hours

Hybrid Work Options

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

-2%

2 year growth

-2%
The Associated Press
Mar 31st, 2026
Niagen Bioscience partners with OneSpaWorld to offer NAD-boosting IV therapy across 80 cruise ship medi-spas

Niagen Bioscience has partnered with OneSpaWorld to offer pharmaceutical-grade Niagen IV at over 80 medi-spa clinics aboard high-end cruise ships, marking the company's first cruise ship clinic partnership. The collaboration extends Niagen Bioscience's clinical footprint, which already includes over 1,200 healthcare, wellness and longevity clinics across the US. Niagen IV contains pharmaceutical-grade nicotinamide riboside, designed to boost NAD+ levels and support cellular vitality and healthy ageing. The formulation offers 75% shorter infusion times compared to traditional NAD+ IV treatments, with fewer side effects. The partnership introduces a new distribution channel for Niagen Bioscience, targeting health-conscious travellers seeking science-backed wellness experiences. Wells Pharma of Houston will compound and distribute the product to qualified OneSpaWorld locations across the cruise fleet.

Yahoo Finance
Mar 24th, 2026
Niagen Bioscience price target cut to $13 as analysts cite injectable upside but trim optimism

Niagen Bioscience remains in focus after Canaccord analyst Susan Anderson lowered the price target from $14 to $13 whilst maintaining a Buy rating, close to the $13.60 fair value estimate. The firm cited strong demand for Niagen's core business following Q4 results and highlighted potential upside from the injectable segment. The company expanded its share buyback programme by $10 million to $20 million total on 19 March 2026. Niagen launched the Skincare Innovation Lab and introduced Niagen NanoCloud, a waterless topical product using its nicotinamide riboside ingredient. Management issued 2026 sales guidance projecting 10% to 15% year-over-year growth, excluding 2025 revenue from its Analytical Reference Standards division, driven by e-commerce and new partnerships.

The Associated Press
Mar 10th, 2026
Niagen Bioscience launches skincare innovation lab with NanoCloud topical product powered by patented NAD+ booster

Niagen Bioscience has launched Niagen Skincare Innovation Lab and introduced Niagen NanoCloud, its first topical skincare product powered by patented nicotinamide riboside. The limited-release product addresses NAD+ degradation in water-based formulations through sealed, waterless sachets that maintain ingredient stability until use. The dermatologist-tested formula combines Niagen with hyaluronic acid, pullulan, squalane and vitamin E. A six-week consumer study of 37 participants showed visible improvements in skin texture, hydration and radiance within two weeks. The launch positions Niagen Bioscience in the global skincare market, valued at $122.11 billion in 2025 and projected to reach $227.13 billion by 2034. Niagen NanoCloud is available on truniagen.com for $59 per 30-sachet unit.

Business Wire
Mar 10th, 2026
Niagen Bioscience launches topical skincare lab with NanoCloud sachets powered by NAD+ science

Niagen Bioscience has launched Niagen Skincare Innovation Lab, a product platform translating its NAD+ science into skincare, and debuted Niagen NanoCloud, a limited-release topical product powered by its patented nicotinamide riboside ingredient. The dermatologist-tested product addresses NAD+ degradation in water-based formulations through a sealed, waterless sachet format that preserves potency until use. When mixed with serum or moisturiser, it delivers a precision-dosed treatment containing hyaluronic acid, pullulan, squalane and vitamin E. A consumer study showed visible improvements in skin texture and hydration within two weeks. The launch targets the global skincare market, valued at $122 billion in 2025 and projected to reach $227 billion by 2034. Niagen NanoCloud is available at truniagen.com for $59, containing 30 sachets.

Yahoo Finance
Mar 5th, 2026
Niagen Bioscience reports 30% revenue growth to $129.4M in 2025, ends year with $64.8M cash and no debt

Niagen Bioscience reported 16% year-over-year revenue growth in Q4 2025, reaching $33.8 million, whilst full-year 2025 net revenue grew 30% to $129.4 million. The Nasdaq-listed company ended the year with $64.8 million in cash and no debt. The firm secured a patent for nicotinamide riboside and derivatives in intravenous and injectable formulations, initially launching one SKU targeting the biohacker and longevity communities. CEO Rob Fried said the injections would be priced lower than IV treatments. However, Niagen faces challenges including increased competition in the NAD space and FDA uncertainty around NMN's dietary supplement status. Its No Park Parkinson's study failed to achieve its primary endpoint. The company projects more conservative 10-15% growth for 2026, down from 2025's 30%.

INACTIVE